KY Biotechnology & Medical Research

Belite Bio Inc (BLTE)

Track

Over the past 90 days, Belite Bio Inc. has seen significant insider selling, totaling approximately $4.3 million in net value. Chief Medical Officer Hendrik Peter Scholl has been the primary seller, executing numerous transactions. This activity follows a recent earnings report that missed expectations, occurring amidst a 9.3% decline in the company's stock price over the same period.
Ticker: BLTE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Belite Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Scholl Hendrik Peter
Chief Medical Officer
10 sales — total 2,904,870 USD
Sale 18 Jun 2026
Value US$3,113,352.19 | Price 128.95 | Shares 88,592
Sale 18 Jun 2026
Value US$299,400.05 | Price 174.91 | Shares 71,047
Sale 18 Jun 2026
Value US$175,347.64 | Price 146.24 | Shares 1,199
Sale 18 Jun 2026
Value US$175,347.64 | Price 146.24 | Shares 1,199
Sale 18 Jun 2026
Value US$706,958.56 | Price 145.43 | Shares 4,861
Sale 18 Jun 2026
Value US$706,958.56 | Price 145.43 | Shares 4,861
Sale 18 Jun 2026
Value US$542,192.05 | Price 144.66 | Shares 3,748
Sale 18 Jun 2026
Value US$542,192.05 | Price 144.66 | Shares 3,748
Sale 18 Jun 2026
Value US$13,814.40 | Price 143.90 | Shares 96
Sale 18 Jun 2026
Value US$13,814.40 | Price 143.90 | Shares 96
Proposed sale 18 Jun 2026
Value US$213,392.18 | Price 443.19 | Shares 83,388
Sale 16 Jun 2026
Value US$150,096.94 | Price 145.02 | Shares 1,035
Sale 16 Jun 2026
Value US$272,314.35 | Price 143.55 | Shares 1,897
Sale 16 Jun 2026
Value US$63,988.11 | Price 142.20 | Shares 450
Sale 16 Jun 2026
Value US$14,183.00 | Price 141.83 | Shares 100
Sale 16 Jun 2026
Value US$75,914.71 | Price 140.58 | Shares 540
Sale 16 Jun 2026
Value US$438,260.48 | Price 139.57 | Shares 3,140
Sale 16 Jun 2026
Value US$108,330.53 | Price 138.18 | Shares 784
Sale 16 Jun 2026
Value US$282,641.29 | Price 137.61 | Shares 2,054
Proposed sale 16 Jun 2026
Value US$1,442,400.00 | Price 144.24 | Shares 10,000
Planned sale 7 May 2026
Value US$1,397.28 | Price 155.25 | Shares 9
Planned sale 7 May 2026
Value US$463.83 | Price 154.61 | Shares 3
Planned sale 7 May 2026
Value US$65,725.18 | Price 153.56 | Shares 428
Planned sale 7 May 2026
Value US$34,453.09 | Price 152.45 | Shares 226
Planned sale 6 May 2026
Value US$15,600.00 | Price 156.00 | Shares 100
Planned sale 6 May 2026
Value US$15,597.00 | Price 155.97 | Shares 100
Planned sale 6 May 2026
Value US$37,058.81 | Price 154.41 | Shares 240
Planned sale 6 May 2026
Value US$19,637.54 | Price 153.42 | Shares 128
Planned sale 6 May 2026
Value US$64,732.80 | Price 152.67 | Shares 424
Planned sale 6 May 2026
Value US$1,212.56 | Price 151.57 | Shares 8
Planned sale 5 May 2026
Value US$10,751.48 | Price 158.11 | Shares 68
Planned sale 5 May 2026
Value US$24,379.90 | Price 157.29 | Shares 155
Planned sale 5 May 2026
Value US$18,940.03 | Price 156.53 | Shares 121
Planned sale 5 May 2026
Value US$26,897.54 | Price 155.48 | Shares 173
Planned sale 5 May 2026
Value US$56,062.92 | Price 154.44 | Shares 363
Planned sale 5 May 2026
Value US$18,470.60 | Price 153.92 | Shares 120
Planned sale 4 May 2026
Value US$27,088.35 | Price 157.49 | Shares 172
Planned sale 4 May 2026
Value US$36,793.41 | Price 156.57 | Shares 235
Planned sale 4 May 2026
Value US$50,441.95 | Price 155.21 | Shares 325
Planned sale 4 May 2026
Value US$36,400.05 | Price 154.24 | Shares 236
Planned sale 4 May 2026
Value US$4,911.84 | Price 153.50 | Shares 32
Planned sale 1 May 2026
Value US$3,680.00 | Price 160.00 | Shares 23
Planned sale 1 May 2026
Value US$6,044.98 | Price 159.08 | Shares 38
Planned sale 1 May 2026
Value US$10,292.62 | Price 158.35 | Shares 65
Planned sale 1 May 2026
Value US$16,689.89 | Price 157.45 | Shares 106
Planned sale 1 May 2026
Value US$12,811.80 | Price 156.24 | Shares 82
Planned sale 1 May 2026
Value US$53,794.70 | Price 155.48 | Shares 346
Planned sale 1 May 2026
Value US$44,461.35 | Price 154.38 | Shares 288
Planned sale 1 May 2026
Value US$8,002.50 | Price 153.89 | Shares 52
Planned sale 30 Apr 2026
Value US$15,972.68 | Price 158.15 | Shares 101
Planned sale 30 Apr 2026
Value US$53,506.38 | Price 157.37 | Shares 340
Planned sale 30 Apr 2026
Value US$80,955.27 | Price 156.59 | Shares 517
Planned sale 30 Apr 2026
Value US$6,538.42 | Price 155.68 | Shares 42
Planned sale 29 Apr 2026
Value US$3,480.27 | Price 158.19 | Shares 22
Planned sale 29 Apr 2026
Value US$16,053.36 | Price 157.39 | Shares 102
Planned sale 29 Apr 2026
Value US$53,029.91 | Price 156.43 | Shares 339
Planned sale 29 Apr 2026
Value US$40,280.41 | Price 155.52 | Shares 259
Planned sale 29 Apr 2026
Value US$42,972.68 | Price 154.58 | Shares 278
Planned sale 28 Apr 2026
Value US$8,755.69 | Price 162.14 | Shares 54
Planned sale 28 Apr 2026
Value US$14,393.14 | Price 161.72 | Shares 89
Planned sale 28 Apr 2026
Value US$19,232.90 | Price 160.27 | Shares 120
Planned sale 28 Apr 2026
Value US$60,579.30 | Price 159.42 | Shares 380
Planned sale 28 Apr 2026
Value US$9,840.06 | Price 158.71 | Shares 62
Planned sale 28 Apr 2026
Value US$34,962.11 | Price 157.49 | Shares 222
Planned sale 28 Apr 2026
Value US$8,300.42 | Price 156.61 | Shares 53
Planned sale 28 Apr 2026
Value US$1,242.87 | Price 155.36 | Shares 8
Planned sale 28 Apr 2026
Value US$1,855.76 | Price 154.65 | Shares 12
Planned sale 27 Apr 2026
Value US$5,906.58 | Price 164.07 | Shares 36
Planned sale 27 Apr 2026
Value US$66,894.94 | Price 163.56 | Shares 409
Planned sale 27 Apr 2026
Value US$37,509.20 | Price 162.38 | Shares 231
Planned sale 27 Apr 2026
Value US$45,253.91 | Price 161.62 | Shares 280
Planned sale 27 Apr 2026
Value US$7,076.72 | Price 160.83 | Shares 44
Planned sale 24 Apr 2026
Value US$487.59 | Price 162.53 | Shares 3
Planned sale 24 Apr 2026
Value US$4,514.20 | Price 161.22 | Shares 28
Planned sale 24 Apr 2026
Value US$52,931.31 | Price 160.40 | Shares 330
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
88,592 -25.8%
128.95
US$3,113,352 		88,592 -25.8% 128.95 US$3,113,352
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
71,047 +1.6%
174.91
US$299,400 		71,047 +1.6% 174.91 US$299,400
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
68,318 -22.5%
354.55
US$1,833,198 		68,318 -22.5% 354.55 US$1,833,198
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,199 -7.4%
146.24
US$175,348 		1,199 -7.4% 146.24 US$175,348
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
4,861 -23.0%
145.43
US$706,959 		4,861 -23.0% 145.43 US$706,959
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,748 -15.0%
144.66
US$542,192 		3,748 -15.0% 144.66 US$542,192
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-22 2026-06-18 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
96 -0.4%
143.90
US$13,814 		96 -0.4% 143.90 US$13,814
2026-06-18 2026-06-18 PrS Proposed sale
Dr. Hendrick P. Scholl

Affiliate
10,000
148.34
US$1,483,400 		10,000 148.34 US$1,483,400
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,035 -4.0%
145.02
US$150,097 		1,035 -4.0% 145.02 US$150,097
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
1,897 -6.8%
143.55
US$272,314 		1,897 -6.8% 143.55 US$272,314
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
450 -1.6%
142.20
US$63,988 		450 -1.6% 142.20 US$63,988
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
100 -0.4%
141.83
US$14,183 		100 -0.4% 141.83 US$14,183
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
540 -1.9%
140.58
US$75,915 		540 -1.9% 140.58 US$75,915
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
3,140 -9.8%
139.57
US$438,260 		3,140 -9.8% 139.57 US$438,260
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
784 -2.4%
138.18
US$108,331 		784 -2.4% 138.18 US$108,331
2026-06-17 2026-06-16 S Sale
Scholl Hendrik Peter

Chief Medical Officer

Officer
2,054 -5.9%
137.61
US$282,641 		2,054 -5.9% 137.61 US$282,641
2026-06-16 2026-06-16 PrS Proposed sale
Dr. Hendrick P. Scholl

Affiliate
10,000
144.24
US$1,442,400 		10,000 144.24 US$1,442,400
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
9 -100.0%
155.25
US$1,397 		9 -100.0% 155.25 US$1,397
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
3 -25.0%
154.61
US$464 		3 -25.0% 154.61 US$464
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
428 -97.3%
153.56
US$65,725 		428 -97.3% 153.56 US$65,725
2026-05-08 2026-05-07 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
226 -33.9%
152.45
US$34,453 		226 -33.9% 152.45 US$34,453
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
100 -13.1%
156.00
US$15,600 		100 -13.1% 156.00 US$15,600
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
100 -11.5%
155.97
US$15,597 		100 -11.5% 155.97 US$15,597
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
240 -21.7%
154.41
US$37,059 		240 -21.7% 154.41 US$37,059
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
128 -10.4%
153.42
US$19,638 		128 -10.4% 153.42 US$19,638
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
424 -25.6%
152.67
US$64,733 		424 -25.6% 152.67 US$64,733
2026-05-07 2026-05-06 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
8 -0.5%
151.57
US$1,213 		8 -0.5% 151.57 US$1,213
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
68 -3.9%
158.11
US$10,751 		68 -3.9% 158.11 US$10,751
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
155 -8.2%
157.29
US$24,380 		155 -8.2% 157.29 US$24,380
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
121 -6.0%
156.53
US$18,940 		121 -6.0% 156.53 US$18,940
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
173 -7.9%
155.48
US$26,898 		173 -7.9% 155.48 US$26,898
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
363 -14.3%
154.44
US$56,063 		363 -14.3% 154.44 US$56,063
2026-05-06 2026-05-05 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
120 -4.5%
153.92
US$18,471 		120 -4.5% 153.92 US$18,471
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
172 -6.1%
157.49
US$27,088 		172 -6.1% 157.49 US$27,088
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
235 -7.6%
156.57
US$36,793 		235 -7.6% 156.57 US$36,793
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
325 -9.6%
155.21
US$50,442 		325 -9.6% 155.21 US$50,442
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
236 -6.5%
154.24
US$36,400 		236 -6.5% 154.24 US$36,400
2026-05-05 2026-05-04 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
32 -0.9%
153.50
US$4,912 		32 -0.9% 153.50 US$4,912
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
23 -0.6%
160.00
US$3,680 		23 -0.6% 160.00 US$3,680
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
38 -1.0%
159.08
US$6,045 		38 -1.0% 159.08 US$6,045
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
65 -1.7%
158.35
US$10,293 		65 -1.7% 158.35 US$10,293
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
106 -2.7%
157.45
US$16,690 		106 -2.7% 157.45 US$16,690
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
82 -2.1%
156.24
US$12,812 		82 -2.1% 156.24 US$12,812
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
346 -8.0%
155.48
US$53,795 		346 -8.0% 155.48 US$53,795
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
288 -6.2%
154.38
US$44,461 		288 -6.2% 154.38 US$44,461
2026-05-04 2026-05-01 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
52 -1.1%
153.89
US$8,002 		52 -1.1% 153.89 US$8,002
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
101 -2.1%
158.15
US$15,973 		101 -2.1% 158.15 US$15,973
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
340 -6.7%
157.37
US$53,506 		340 -6.7% 157.37 US$53,506
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
517 -9.2%
156.59
US$80,955 		517 -9.2% 156.59 US$80,955
2026-05-01 2026-04-30 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
42 -0.7%
155.68
US$6,538 		42 -0.7% 155.68 US$6,538
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
22 -0.4%
158.19
US$3,480 		22 -0.4% 158.19 US$3,480
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
102 -1.8%
157.39
US$16,053 		102 -1.8% 157.39 US$16,053
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
339 -5.5%
156.43
US$53,030 		339 -5.5% 156.43 US$53,030
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
259 -4.1%
155.52
US$40,280 		259 -4.1% 155.52 US$40,280
2026-04-30 2026-04-29 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
278 -4.2%
154.58
US$42,973 		278 -4.2% 154.58 US$42,973
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
54 -0.8%
162.14
US$8,756 		54 -0.8% 162.14 US$8,756
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
89 -1.3%
161.72
US$14,393 		89 -1.3% 161.72 US$14,393
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
120 -1.7%
160.27
US$19,233 		120 -1.7% 160.27 US$19,233
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
380 -5.2%
159.42
US$60,579 		380 -5.2% 159.42 US$60,579
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
62 -0.8%
158.71
US$9,840 		62 -0.8% 158.71 US$9,840
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
222 -2.9%
157.49
US$34,962 		222 -2.9% 157.49 US$34,962
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
53 -0.7%
156.61
US$8,300 		53 -0.7% 156.61 US$8,300
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
8 -0.1%
155.36
US$1,243 		8 -0.1% 155.36 US$1,243
2026-04-29 2026-04-28 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
12 -0.2%
154.65
US$1,856 		12 -0.2% 154.65 US$1,856
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
36 -0.5%
164.07
US$5,907 		36 -0.5% 164.07 US$5,907
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
409 -5.0%
163.56
US$66,895 		409 -5.0% 163.56 US$66,895
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
231 -2.8%
162.38
US$37,509 		231 -2.8% 162.38 US$37,509
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
280 -3.2%
161.62
US$45,254 		280 -3.2% 161.62 US$45,254
2026-04-28 2026-04-27 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
44 -0.5%
160.83
US$7,077 		44 -0.5% 160.83 US$7,077
2026-04-27 2026-04-24 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
3 -0.0%
162.53
US$488 		3 -0.0% 162.53 US$488
2026-04-27 2026-04-24 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
28 -0.3%
161.22
US$4,514 		28 -0.3% 161.22 US$4,514
2026-04-27 2026-04-24 PlS Planned sale
MATA NATHAN L.

Chief Scientific Officer

Officer
330 -3.7%
160.40
US$52,931 		330 -3.7% 160.40 US$52,931
Explore more

More insider trading research around Belite Bio Inc

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity